Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis
Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis
复制标题
DOI:
10.1016/j.atherosclerosis.2009.05.036
复制
发表时间:
2009-12-01
期刊:
影响因子:
5.3
通讯作者:
Williams, M. J. A.
中科院分区:
文献类型:
--
作者:
Jones, G. T.;Tarr, G. P.;Williams, M. J. A.
Objective: This study aimed to determine whether plasma levels of active matrix metalloproteinases (MMP) are predictors of in-stent restenosis (ISR) in New Zealand patients treated with bare-metal coronary stents.Methods: A group of 152 patients with a history of ISR were compared with 151 symptom free 1-year post-stenting patients (non-ISR). Demographic and angiographic characteristics were collected. Plasma samples were analyzed for the active forms of MMP-1, -2, -3 and -9 as well as tissue inhibitor of metalloproteinases (TIMP-1) using ELISA-based isoform sensitive assays.Results: Both active MMP-9 and active MMP-3 were independently associated with history of ISR. Elevated levels of both active MMP-3 and -9 had an adjusted odds ratio of 11.8 (95% CI: 4-35, p < 0.0001) for association with ISR, with 37% of ISR patients having such levels versus 11% on non-ISR. The addition of both of the MMP biomarkers significantly increased the area under the curve (AUC) of a receiver operator characteristic (ROC) analysis incorporating the significant demographic and angiographic variables ( AUC 0.85 versus 0.78, p < 0.005).Conclusion: Measures of plasma active MMP isoforms appear to be independently associated with ISR, and assessment of multiple MMP markers yields cumulative utility. (c) 2009 Elsevier Ireland Ltd. All rights reserved.